Antihypertensive Meds Recalled Due to Nitrosamine Impurity
N-nitroso-irbesartan is a probable human carcinogen based on results from laboratory tests.
Diabetic Nephropathy
Researchers Study the Potential Impact of Dapagliflozin on Diabetic Kidney Disease
A large multinational study examined the potential impact of dapagliflozin on kidney disease in people with type 2 diabetes.
Finerenone Provides CV, Renal Benefits in Diabetes Across CKD Spectrum
In FIDELITY, investigators pooled data from more than 13,000 patients from the FIDELIO-DKD and FIGARO-DKD trials.
Frailty Ups Risk for Urinary Tract Infections in Patients With Diabetes, CKD
More severe frailty predicted a higher risk of UTIs.
Free Fatty Acids Associated With Rapid Decline in Glomerular Filtration Rates in Type 1 Diabetes
Researchers identified lipidomic predictors of rapid decline of kidney function in individuals with type 1 diabetes.
Dapagliflozin Safe, Effective in Advanced Chronic Kidney Disease
Dapagliflozin’s benefits among patients with stage 4 CKD were consistent with those observed in the larger DAPA-CKD cohort with stage 2-3 CKD.
High iPTH Linked With Cardiovascular Outcomes in Diabetic Kidney Disease
Study findings indicate a correlation between iPTH and vascular calcification in patients with diabetic kidney disease.
Kerendia Approved to Reduce CKD Progression, CV Risk in Patients With Diabetic Kidney Disease
The approval was based on data from the phase 3 FIDELIO-DKD trial.
Efpeglenatide Improves Renal, Cardiovascular Outcomes in High-Risk Diabetes
Among the patients with high-risk diabetes in the trial, 21.8% had both a history of cardiovascular disease and current kidney disease.
Four in 10 Diabetes Patients Have Kidney Disease
More than one-quarter are classified as rapid decliners, which was more common with type 2 diabetes
- Loading...
Loading...
Next post in Diabetic Nephropathy
Loading... 
Loading...